Association of bone metabolism related genes polymorphisms with the effect of raloxifene hydrochloride on bone mineral density and bone turnover markers in postmenopausal women with osteoporosis

Chinese Journal of Medical Genetics

Volumn 23, Issue 2, 2006, Pages 129-133

  Zhang, Zhen Lin ^a   He, Jin Wei ^a   Qin, Yue Juan ^a   Huang, Qi Ren ^a   Liu, Yu Juan ^a   Hu, Yun Qiu ^a   Li, Miao ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Genetic polymorphism; Postmenopausal osteoporosis; Raloxifene hydrochloride

Indexed keywords

CARBOXY TERMINAL TELOPEPTIDE; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR 1; OSTEOCALCIN; PLACEBO; RALOXIFENE; TRANSCRIPTION FACTOR CDX2; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

ADULT; AGED; ARTICLE; BINDING SITE; BONE DENSITY; BONE METABOLISM; BONE TURNOVER; CONTROLLED STUDY; DNA POLYMORPHISM; DRUG EFFECT; ETHNOLOGY; FEMALE; FEMUR TROCHANTERIC FRACTURE; GENE; GENOTYPE; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; ONCOGENE RAS; OSTEOPOROSIS; POSTMENOPAUSE; PVU II GENE; START CODON; XBA I GENE;

AGED; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; BONE DISEASES, METABOLIC; BONE REMODELING; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MIDDLE AGED; OSTEOPOROSIS; OSTEOPOROSIS, POSTMENOPAUSAL; POLYMORPHISM, GENETIC; POSTMENOPAUSE; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATORS; WOMEN;

EID: 33646088953     PISSN: 10039406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Zhang ZL, Zhao JX, Meng XW, et al. Association of polymorphisms of vitamin D receptor gene codon and 3′-end region with bone mineral density in postmenopausal women. Chin J Med Genet, 2003, 20:5-8.
2. Zhang ZL, Qin YJ, He JW, et al. Association of Xba I, Pvu II, and Bst U I polymorphisms of estrogen receptor-α gene with bone mass in men. Chin J Med Genet, 2005, 22:447-449.
3. Krauss RM. Individualized hormone-replacement therapy? N Engl J Med, 2002, 346:1017-1018.
4. Holzman NA, Marteau TM. Will genetics revolutionize medicine? N Engl J Med, 2000, 343:141-144.
5. Palomba S, Numis FG, Mossetti G, et al. Raloxifene administration in post-menopausal women with osteoporosis: effect of different Bsm I vitamin D receptor genotypes. Hum Reprod, 2003, 18: 192-198.
6. Huang QR, Zhou Q, Lu JH, et al. Bone mineral density and age-related bone loss in 2111 healthy women in Shanghai. Chin J Osteoporos, 2002, 8:191-194.
7. Qin YJ, Zhang ZL, Huang QR, et al. Association of vitamin D receptor and estrogen receptor α gene polymorphism with peak bone mass and bone size in Chinese women. Acta Pharmacol Sin, 2004, 25:462-468.
8. Wang Z, Yoshida S, Negoro K, et al. Polymorphisms in the estrogen receptor β gene but not estrogen receptor α gene affect the risk of developing endometriosis in a Japanese population. Fertil Steril, 2004, 81:1650-1656.
9. Arai H, Miyamoto K, Takatari Y, et al. A vitamin D receptor gene polymorphisms in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women. J Bone Miner Res, 1997, 12:915-921.
10. Fang Y, van Meurs JB, Bergink AP, et al. Cdx-2 polymorphism in the promoter region of the human vitamin D receptor gene determiners susceptibility to fracture in the elderly. J Bone Mineral Res, 2003, 18:1632-1641.
11. Johnell O, Kanis JA, Black DM, et al. Association between baseline risk factors and vertebral fracture risk in the multiple outcomes of Raloxifene evaluation (MORE) study. J Bone Miner Res, 2004, 19:764-772.
12. He JW, Huang QR, Zhang ZL, et al. Association of polymorphisms of estrogen receptor α and vitamin D receptor genes with peak bone mass in Shanghai women. Chin J Endocrinol Metab, 2004, 20:140-142.
13. Zhang ZL, Qin YJ, Huang QR, et al. Association of estrogen receptor-alpha and vitamin D receptor genotypes with therapeutic response to calcium in postmenopausal Chinese women. Acta Pharmacol Sin, 2004, 25:1690-1697.